Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.

Autor: Jespersen SS; Departments of Pathology., Stovgaard ES; Departments of Pathology., Nielsen D; Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Christensen TD; Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Buhl ASK; Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Christensen IJ; Departments of Pathology., Balslev E; Departments of Pathology.

Publikováno v: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2021 Jan; Vol. 29 (1), pp. e5-e9.

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Autor: Buhl ASK; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark. anna-buhl@hotmail.com.; Medical Prognosis Institute, Hoersholm, Denmark. anna-buhl@hotmail.com., Christensen TD; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark., Christensen IJ; Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark., Nelausen KM; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark., Balslev E; Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark., Knoop AS; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Brix EH; Department of Oncology, Nordsjaellands Hospital, Copenhagen University Hospital, Hilleroed, Denmark., Svensson E; Department of Oncology, Zealand University Hospital, Roskilde, Naestved, Denmark., Glavicic V; Department of Oncology, Zealand University Hospital, Roskilde, Naestved, Denmark., Luczak A; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Langkjer ST; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Linnet S; Department of Oncology, Regional Hospital West Jutland, Herning, Denmark., Jakobsen EH; Department of Oncology, Vejle Sygehus, Vejle, Denmark., Bogovic J; Department of Oncology, Hospital of Southern Jutland, Soenderborg, Denmark., Ejlertsen B; The Danish Breast Cancer Cooperative Group, DBCG Secretariat, Rigshospitalet, Copenhagen, Denmark., Rasmussen A; Medical Prognosis Institute, Hoersholm, Denmark., Hansen A; Medical Prognosis Institute, Hoersholm, Denmark., Knudsen S; Medical Prognosis Institute, Hoersholm, Denmark., Nielsen D; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark., Jensen PB; Medical Prognosis Institute, Hoersholm, Denmark.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Nov; Vol. 172 (2), pp. 391-400. Date of Electronic Publication: 2018 Aug 11.